NF 1819 是一种有效且选择性的不可逆 MGL(β;-内酰胺基单酰基甘油脂肪酶)抑制剂。
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
Potent and selective irreversible MAGL inhibitor (IC50 values are 0.25 and 7.4 nM at rMAGL and hMAGL, respectively). Exhibits 389-fold selectivity over hFAAH and exhibits minimal binding at CB receptors (IC50 > 10 μM). Alleviates symptoms in a MS in vivo model. Exhibits analgesic effects in an acute inflammatory pain model in vivo. Ameliorates neuropathic hypersensitivity induced by oxaliplatin . Displays high membrane permeability and brain penetrant.
Brindisi et al (20106) Development and pharmacological characterization of selective blockers of 2-arachidonoyl glycerol degradation with efficacy in rodent models of multiple sclerosis and pain. J.Med.Chem. 59 2612 PMID:26888301
没有评价数据